Follow

Submissions from 2018

PDF

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors, Fernando Vargas Madueno, Edwin Gould, Raul Valor, and Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero

PDF

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden, Miguel Villalona Calero and Zuanel Diaz
Open Access

Submissions from 2017

PDF

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, Michael Troner
Full Text Restricted – Available from BHSF IP or login only

Submissions from 2016

Global Overview of Colorectal Cancer ― Past, Present and Future, Antonio Ucar

PDF

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only